Self-help plus (SH+) for South Sudanese refugees in Uganda

Conditions

Psychological distress Mental and Behavioural Disorders Psychological distress

Jura Augustinavicius, Marianna Purgato, Federico Tedeschi, Rashelle J. Musci, Marx R. Leku et al. (13 authors)

BMJ Open2023-09-0112 citations

10.1136/bmjopen-2020-048043

Self Help Plus: study protocol for a cluster-randomised controlled trial of guided self-help with South Sudanese refugee women in Uganda

Felicity L. Brown, Kenneth Carswell, Jura Augustinavicius, Alex Adaku, Marx R. Leku et al. (13 authors)

Cambridge Prisms Global Mental Health2018-01-0122 citations

10.1017/gmh.2018.17

Interventions

Villages in the Rhino Camp refugee resettlement area are randomised to the following two conditions. Interviewers will be masked for study condition of villages. 1. The intervention co

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Adults (18 years or older) 2. Women 3. Speaking Juba Arabic 4. Residing in the Rhino Camp refugee settlement area in the West Nile region in northern Uganda 5. Scoring above an established cut-off for psychological distress on the K6

Exclusion criteria

Exclusion criteria: 1. Imminent risk of suicide 2. Observable signs of severe mental disorder

Design outcomes

Primary

Measure	Time frame
Psychological distress, assessed using the Kessler 6 (K6) at pre-treatment (included as screening measure), immediately post-treatment, and 3 months after completion of treatment	—

Secondary

Measure	Time frame
Secondary outcomes: 1. Functional impairment, measured using the World Health Organization Disability Assessment Schedule 2.0, 12-item, interviewer administered version 2. Self-defined psychosocial goals, measured using PSYCLOPS 3. Depression symptoms, measured using the Patient Health Questionnaire 9 (PHQ-9) 4. Post-traumatic stress disorder symptoms, measured using the Posttraumatic Checklist 6 Civilian Version (PCL-C6) 5. Subjective wellbeing, measured using the World Health Organization Wellbeing 5 (WHO-5) Mediator: 1. Psychological flexibility, measured using the Acceptance and Action Questionnaire 2 (AAQ-2) Moderators: 1. Exposure to potentially traumatic events, measured using the Harvard Trauma Questionnaire (HTQ), part A 2. (Additional) health service use, measured using survey questions designed for this study Other: 1. Economic indicators (for cost-benefit analyses), measured using survey questions designed for this study 2. Treatment contamination check, measured using survey questions designed for this study All outcomes, mediators, moderators and the economic indicators are assessed at pre-treatment, immediately post-treatment, and 3 months after completion of treatment by a masked team of interviewers not involved in service delivery. To ensure masking, the contamination measure will be administered by intervention facilitators, between the immediate post-treatment follow-up and the 3-month follow-up.	—

Measure

Time frame

Secondary outcomes: 1. Functional impairment, measured using the World Health Organization Disability Assessment Schedule 2.0, 12-item, interviewer administered version 2. Self-defined psychosocial goals, measured using PSYCLOPS 3. Depression symptoms, measured using the Patient Health Questionnaire 9 (PHQ-9) 4. Post-traumatic stress disorder symptoms, measured using the Posttraumatic Checklist 6 Civilian Version (PCL-C6) 5. Subjective wellbeing, measured using the World Health Organization Wellbeing 5 (WHO-5) Mediator: 1. Psychological flexibility, measured using the Acceptance and Action Questionnaire 2 (AAQ-2) Moderators: 1. Exposure to potentially traumatic events, measured using the Harvard Trauma Questionnaire (HTQ), part A 2. (Additional) health service use, measured using survey questions designed for this study Other: 1. Economic indicators (for cost-benefit analyses), measured using survey questions designed for this study 2. Treatment contamination check, measured using survey questions designed for this study All outcomes, mediators, moderators and the economic indicators are assessed at pre-treatment, immediately post-treatment, and 3 months after completion of treatment by a masked team of interviewers not involved in service delivery. To ensure masking, the contamination measure will be administered by intervention facilitators, between the immediate post-treatment follow-up and the 3-month follow-up.

—

Countries

Uganda

Outcome results

None listed